In the Lab
Researchers Discover New Cancer Cell Vulnerability: Droplets in the Nucleus
SKI researchers have learned how tiny droplets prevent a cancer-causing type of messenger RNA from being degraded in leukemia cells.
In the Lab
Fructose Could Play a Role in Targeting Leukemia
Leukemia cells metabolize fructose in a way that could make them easier to target with drugs.
In the Lab
Novel Tool Enables Study of Rare Acute Myeloid Leukemia Stem Cells
MSK investigators have used a lab tool originally developed to study fly nerve cells to uncover new findings about acute myeloid leukemia.
In the Lab
How Stem Cells Decide Their Fate
Research in blood stem cells has revealed new information about how these cells decide what to become when they divide.
In the Lab
Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal
Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
In the Lab
Something New Under the Sun: Study in Leukemia Finds Role for Helios Protein
MSK researchers have found that a protein that contributes to one type of leukemia when it’s missing can lead to the formation of a different leukemia type when it’s present.
In the Lab
Step by Step: Stem Cell Approach Provides New Models for Studying How Acute Myeloid Leukemia Progresses
A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia.
Imagination to Discovery
Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering.
At Work: Cancer Biologist Michael Kharas
Cancer biologist Michael Kharas explores molecular processes that stem cells and tumor cells have in common.
